Brand Reference: Prozac
| Metric | Verified Benchmark | Source |
|---|---|---|
| Fluoxetine Hydrochloride RxNorm Concept ID | 4493 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0280 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $26.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $4.80 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $5.80 / mo | 49 Zero-PHI Verified Patient Logs |
Blocks presynaptic SERT while weakly antagonizing 5-HT2C receptors (disinhibiting prefrontal norepinephrine and dopamine release for daytime energy) and generating ultra-long-acting norfluoxetine that virtually eliminates SSRI discontinuation brain-zaps.
CMS National Average Drug Acquisition Cost (NADAC) tracking places Fluoxetine Hydrochloride (Prozac, RxCUI 4493) at $0.0280 per unit, whereas walk-in chain pharmacies bill cash patients an average of $26.00 monthly—creating a 82% ($21.20/mo) wholesale arbitrage spread down to $4.80.
Systemic exposure to Fluoxetine Hydrochloride reflects 72% oral absorption kinetics and hepatic cyp2d6 (strong autoinhibitor) and cyp2c9 demethylation, sustaining receptor engagement across a 4–6 days fluoxetine / 9–16 days active norfluoxetine half-life window (3–5 weeks steady-state accumulation response profile).
Dosing protocols (10 mg PO QAM or 20 mg PO QAM or 40 mg PO QAM or 60 mg PO QAM) balance efficacy (85.30% patient satisfaction across 49 logs) against sexual attenuation (22% of reports), early-week restlessness/jitteriness (19% of reports), insomnia if taken pm (17% of reports), with strict avoidance in maoi within 14 days prior (or wait 5 full weeks after stopping fluoxetine before starting maoi); thioridazine or pimozide.
Across 49 verified cash-pay logs, Fluoxetine Hydrochloride achieves a 85.30% Worth-It rating with out-of-pocket spend averaging $5.80/mo versus $26.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 10 mg PO QAM for Fluoxetine Hydrochloride; monthly out-of-pocket dropped to $4.50 compared with $26.00 retail.
Completed 10 weeks on Fluoxetine Hydrochloride (20 mg PO QAM). Zero notable side effects on steady dosing.
Consistent biomarker response on 40 mg PO QAM Fluoxetine Hydrochloride sourced via Cash Clinic ($5.57/mo cash pay without insurance prior authorization).